NCT04212221 2024-07-23
MGD013 Monotherapy and Combination With Brivanib Dose Escalation and Expansion Study in Advanced Liver Cancer Patients
Zai Lab (Hong Kong), Ltd.
Phase 1/2 Terminated
Clinical Trials
4 trialsNCT01253668 2021-04-13
Brivanib Metastatic Renal Cell Carcinoma
Abramson Cancer Center at Penn Medicine
Phase 2 Terminated
NCT01108705 2015-10-12
BRISK-APS
Bristol-Myers Squibb
Phase 3 Terminated
NCT00300027 2010-03-02
Study of BMS-582664 in Combination With Either FOLFIRI or FOLFOX for Gastrointestinal (GI) Malignancies
Bristol-Myers Squibb
Phase 1 Terminated